|
What Makes Epithelial Cells Change Their Identity? (Science Daily)
During development and during pathological processes in the adult, cells are constantly changing their function. One, well-characterized, cellular transition that occurs during development, as well as during wound healing, tissue fibrosis, and tumor metastasis, is the transition from an epithelial cell to a mesenchymal cell (often a fibroblast).
(Feb 6, 2007)
FDA clears MammaPrint test for marketing (News-Medical-Net)
The Food and Drug Administration (FDA) has cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity.
(Feb 6, 2007)
FDA OKs Breast Cancer Recurrence Test (CBS News)
The FDA has approved a gene-based breast cancer test that helps tell early-stage breast cancer patients whether they need chemotherapy after surgery.
(Feb 6, 2007)
The brains behind the bowl (The Arizona Republic)
Super Bowl XLII will require millions of sponsorship dollars and thousands of volunteers. But it also will require a vision and detailed game plan. Here are profiles of Arizona Super Bowl Host Committee executive board members and Glendale officials who are charged with the task of developing both.
(Feb 6, 2007)
New exhibit details human origins (AP via Yahoo! News)
In the beginning were the bones. Fossils dating back hundreds of thousands- even millions- of years used by anthropologists to trace how the human species evolved.
(Feb 6, 2007)
New Exhibit Details Human Origins (AP via Yahoo! Asia News)
In the beginning were the bones.
(Feb 6, 2007)
X PRIZE Opens Registration for Northrop Grumman Lunar Lander Challenge (SpaceRef)
X PRIZE today announced registration dates and rules changes for the $2 million Northrop Grumman Lunar Lander Challenge, which will require a vehicle to simulate trips between the moon's surface and lunar orbit.
(Feb 7, 2007)
New exhibit details human origins (MSNBC)
A new exhibition hall at the American Museum of Natural History is breaking ground by using fossils and genomics to tell the story of human development and evolution.
(Feb 7, 2007)
New exhibit details human origins (AP via Yahoo! News)
In the beginning were the bones. Fossils dating back hundreds of thousands- even millions- of years used by anthropologists to trace how the human species evolved.
(Feb 7, 2007)
Current Issue: (California Aggie)
What research are you doing right now? I'm working with this program called CLIMB, Collaborative Learning at the Interface of Mathematics and Biology. It's a year-long research program in mathematical biology and we cover a lot of subjects.
(Feb 7, 2007)
New test shows which breast cancers will recur (News-Medical-Net)
Approval has been granted by the FDA for a gene-based test that helps tell early-stage breast cancer patients whether they need chemotherapy after their surgery.
(Feb 7, 2007)
TWO NEW 'SUGAR PROBES' FOR CANCER SPREAD DEVELOPED (Central News Agency)
Taipei, Feb. 7 (CNA) Researchers at Academia Sinica's Genomics Research Center have developed two new "sugar probes" that can target abnormal proteins in cancer cells to facilitate studies on cancer metastasis, academic sources said Wednesday.
(Feb 7, 2007)
Acacia Technologies Licenses Image Resolution Enhancement Technology to Lexmark (Business Wire via Yahoo! Finance)
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that IP Innovation, LLC a wholly owned subsidiary that is a part of the Acacia Technologies group, has entered into a License Agreement with Lexmark International, Inc. covering patents that apply to Image Resolution Enhancement Technology.
(Feb 7, 2007)
FDA Clears Breast Cancer Specific Molecular Prognostic Test (Kansas City InfoZine)
The U.S. Food and Drug Administration (FDA) today cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity.
(Feb 7, 2007)
Acacia Technologies Licenses Image Resolution Enhancement Technology to Lexmark (Broadcast Newsroom)
NEWPORT BEACH, Calif.,
(Feb 7, 2007)
Matritech, Inc. (AMEX: MZT) Q4/06 Review Issued by Scimitar Equity Research, Inc. (PR Newswire via Yahoo! Finance)
Scimitar Equity Research, Inc. issues a review on Matritech, Inc. entitled ""Encouraging Q4 and FY06 Results, Financing, AMEX Compliance and FY07 Guidance".
(Feb 7, 2007)
Loss of a universal tRNA feature reported (EurekAlert!)
Blacksburg, Va. – Scientists at the Virginia Bioinformatics Institute (VBI) report in the Journal of Bacteriology that two alphaproteobacteria lack the universal extra guanylate nucleotide typically found in the transfer RNA molecule tRNAHis. tRNAs are the molecules responsible for decoding sequence information specified by messenger RNA molecules, information which is ultimately encoded by the ...
(Feb 7, 2007)
Enzo Biochem Life Sciences Unit Awarded Two Patents That Enhance Competitive Position of Existing Products For ... (Business Wire via Yahoo! Finance)
NEW YORK----Enzo Biochem, Inc. announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted two new patents by the U.S. Patent and Trademark Office that will complement and strengthen existing proprietary labeling products for the genomics and diagnostics markets.
(Feb 7, 2007)
FDA approves molecular breast cancer test (Moldova.org)
The U.S. Food and Drug Administration has approved a test that determines the likelihood of breast cancer returning within 10 years after treatment.The specific molecular prognostic test is the first FDA-approved molecular test that profiles genetic activity.The MammaPrint test uses molecular technology to predict whether existing cancer will metastasize. The test relies on microarray analysis, a ...
(Feb 7, 2007)
United Press International ® News. Analysis. Insight.™ (UPI)
WASHINGTON, Feb. 7 (UPI) -- The U.S. Food and Drug Administration has approved a test that determines the likelihood of breast cancer returning within 10 years after treatment.
(Feb 7, 2007)
Enzyme Wakes Sleeping Genes (Science Daily)
Scientists at the German Cancer Research Center discover an enzyme that activates epigenetically silenced genes. For several years now, cancer researchers have been studying a mechanism that contributes to the development of malignant tumors: The cell attaches small molecules containing a carbon atom, called methyl groups, to specific building blocks of DNA, thereby individually switching off the ...
(Feb 7, 2007)
Horse Genome Assembled: Thoroughbred Mare's DNA Code Now Freely Available (Science Daily)
The first draft of the horse genome sequence has been deposited in public databases and is freely available for use by biomedical and veterinary researchers around the globe, leaders of the international Horse Genome Sequencing Project announced today.
(Feb 7, 2007)
Law Firm Asks USPTO to Reexamine Two OGT Microarray Patents (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Feb 7, 2007)
Loss of a universal tRNA feature (News-Medical-Net)
Scientists at the Virginia Bioinformatics Institute (VBI) report in the Journal of Bacteriology that two alphaproteobacteria lack the universal extra guanylate nucleotide typically found in the transfer RNA molecule tRNAHis.
(Feb 7, 2007)
FDA Approves Molecular Breast Cancer Test (RedNova)
The U.S. Food and Drug Administration has approved a test that determines the likelihood of breast cancer returning within 10 years after treatment. The specific molecular prognostic test is the first FDA-approved molecular test that profiles genetic activity.
(Feb 7, 2007)
FDA OKs Breast Cancer Recurrence Test (MedicineNet.com)
Title: FDA OKs Breast Cancer Recurrence Test Category: Health News Created: 2/7/2007 Last Editorial Review: 2/7/2007
(Feb 7, 2007)
Luminex Corporation Reports Fourth Quarter and Year-End 2006 Results (PR Newswire via Yahoo! Finance)
Luminex Corporation today announced financial results for the fourth quarter and year ended December 31, 2006.
(Feb 7, 2007)
Affymetrix Reports Fourth Quarter and Fiscal Year 2006 Results (Business Wire via Yahoo! Finance)
SANTA CLARA, Calif.----Affymetrix Inc., today reported its operating results for the fourth quarter and fiscal year ended December 31, 2006. On a GAAP basis, the Company reported net income of approximately $8.7 million or $0.13 per diluted share in the fourth quarter of 2006 as compared to net income of $30.6 million or $0.43 per diluted share in the fourth quarter of 2005.
(Feb 7, 2007)
Affymetrix's Q4 profit falls to $8.7M (BizJournals)
Affymetrix Inc. on Wednesday reported fourth quarter net income of $8.7 million, or 13 cents a share, compared to the year-ago period's $30.6 million, or 43 cents a share.
(Feb 7, 2007)
Affymetrix fourth-quarter net falls (Market Watch)
NEW YORK (MarketWatch) -- Affymetrix Inc. said fourth-quarter net earnings fell to $8.7 million, or 13 cents a share, from year-earlier profit of $30.6 million, or 43 cents a share.
(Feb 7, 2007)
United Press International ® News. Analysis. Insight.™ (UPI)
SEVILLE, Spain, Feb. 7 (UPI) -- Spanish medical researchers say they have discovered a new potential benefit of olive oil for people suffering from peptic ulcer disease.
(Feb 7, 2007)
UPI NewsTrack Health and Science News (Moldova.org)
New medical use for olive oil suggestedSEVILLE, Spain, Feb. 7 (UPI) -- Spanish medical researchers say they have discovered a new potential benefit of olive oil for people suffering from peptic ulcer disease.The scientists say extra virgin olive oil -- already providing an array of health benefits -- might help prevent and treat Helicobacter pylori infections, which cause millions of cases of ...
(Feb 7, 2007)
CITY SCIENCE COULD SAVE LIVES (Sunderland Echo)
Scientists from Complement Genomics are set to make a breakthrough in genetic tests which could predict the risk of deep vein thrombosis (DVT), a condition that kills about 20,000 people every year.
(Feb 8, 2007)
United Press International ® News. Analysis. Insight.™ (UPI)
SEVILLE, Spain, Feb. 7 (UPI) -- Spanish medical researchers say they have discovered a new potential benefit of olive oil for people suffering from peptic ulcer disease.
(Feb 8, 2007)
CEO Radio Network Announces Interviews with Executives of Debt Resolve and Power3 Medical Products, Inc. (PRWeb via Yahoo! News)
The CEO Radio Network is pleased to announce that it has posted exclusive interviews with the following companies on the www.
(Feb 8, 2007)
Fresh Starts: Entrepreneurs To Debut in New Roles at Luncheon (Local Tech Wire)
RESEARCH TRIANGLE — Editor's note: BioWatch is a regular feature on Fridays. Two spinouts from Triangle Universities led by locally well-known serial entrepreneurs present at the Council for Entrepreneurial Development's Capital Connection luncheon on Sept. 10.
(Feb 8, 2007)
US FDA clears breast cancer test (PharmaBiz)
The US Food and Drug Administration (FDA) cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity.
(Feb 8, 2007)
FDA clears genomic test for breast cancer (Cancerfacts.com)
WASHINGTON, D.C. – Feb. 8, 2007 – A new test that determines the likelihood of cancer returning within five to 10 years after treatment for breast cancer was given a thumbs up by the FDA yesterday.
(Feb 8, 2007)
CEO Radio Network Announces Interviews with Executives of Debt Resolve and Power3 Medical Products, Inc. (PR Web)
The CEO Radio Network is pleased to announce that it has posted exclusive interviews with the following companies on the www.ceoradionetwork.com website: Debt Resolve (AMEX:DRV) and Power3 Medical Products, Inc. (PWRM.PK). DRV: Chairman and Chief Executive Officer James Burchetta discusses Debt Resolve's patented online bidding system for the resolution of debt. PWRM: Chairman and Chief ...
(Feb 8, 2007)
Giving tired hearts a chance to rest (Orange County Register)
Cardiac surgeon Steven Bolling was out running one day, thinking about dinosaurs. As a parent of an 8-year-old boy, he often had prehistoric creatures on his mind, if only because thousands of plastic ones were under foot at home.
(Feb 8, 2007)
FDA Approves Gene-Based Breast Cancer Test (iVillage Total Health)
The U.S. Food and Drug Administration approved on Tuesday a new genetic test that's designed to determine the likelihood that early stage breast cancer will recur within five to 10 years after treatment.
(Feb 8, 2007)
Prematurity More Accurately Predicted by Advances in Proteomic Technology (Yale University)
New Haven, Conn.
(Feb 8, 2007)
Breast Cancer Recurrence Risk Test Cleared For Marketing (Science Daily)
The U.S. Food and Drug Administration (FDA) has cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity.
(Feb 8, 2007)
Artificial Cells To Fight Disease? (Science Daily)
Carnegie Mellon University's Philip Leduc predicts the use of artificially created cells could be a potential new therapeutic approach for treating diseases in an ever-changing world.
(Feb 8, 2007)
Reports Of Prognostic Tumor Markers Often Inadequate (Science Daily)
Reports of studies of cancer prognostic factors are largely suboptimal, a new study concludes.
(Feb 8, 2007)
Strategic Diagnostics Names Beijing Green Science and Technology as Exclusive Distribution Partner for Water Quality ... (Business Wire via Yahoo! Finance)
NEWARK, Del.----Strategic Diagnostics Inc. - a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and scientific applications, and the Beijing Green Science and Technology Company today recognized the successful completion of their first year of collaboration and confirmed that Beijing Green will continue to be ...
(Feb 8, 2007)
United Press International ® News. Analysis. Insight.™ (UPI)
SEVILLE, Spain, Feb. 7 (UPI) -- Spanish medical researchers say they have discovered a new potential benefit of olive oil for people suffering from peptic ulcer disease.
(Feb 8, 2007)
Nanotechnology meets biology and DNA finds its groove (EurekAlert!)
The object of fascination for most is the DNA molecule. But in solution, DNA, the genetic material that hold the detailed instructions for virtually all life, is a twisted knot, looking more like a battered ball of yarn than the famous double helix. To study it, scientists generally are forced to work with collections of molecules floating in solution, and there is no easy way to precisely single ...
(Feb 8, 2007)
Autism May Be More Prevelant Than Previous Estimates (Science Daily)
The Centers for Disease Control and Prevention (CDC) reported findings today from the first and largest summary of prevalence data from multiple U.S. communities participating in an autism spectrum disorder (ASD) surveillance project. The results showed an average of 6.7 children out of 1,000 had an ASD in the six communities assessed in 2000, and an average of 6.6 children out of 1,000 having an ...
(Feb 8, 2007)
Foolish Forecast: LabCorp Tests Positive (The Motley Fool)
A major new contract bodes well for the lab-testing firm's future.
(Feb 8, 2007)
|
